METHODS: A rapid proteomic method was developed to detect and quantify the most clinically relevant antimicrobial resistance effectors in S. aureus in the context of sepsis: PBP2a, PBP2c, APH(3\')-III, ANT(4\')-I, and AAC(6\')-APH(2\'\'), directly from positive blood cultures and in less than 70 min including a 30-min cefoxitin-induction step. The method was tested on spiked blood culture bottles inoculated with 124 S.aureus, accounting for the known genomic diversity of SCCmec types and the genetic background of the strains.
RESULTS: This method provided 99% agreement for PBP2a (n = 98/99 strains) detection. Agreement was 100% for PBP2c (n = 5/5), APH(3\')-III (n = 16/16), and ANT(4\')-I (n = 20/20), and 94% for AAC(6\')-APH(2\'\') (n = 16/17). Across the entire strain collection, 100% negative agreement was reported for each of the 5 resistance proteins. Additionally, relative quantification of ANT(4\')-I expression allowed to discriminate kanamycin-susceptible and -resistant strains, in all strains harbouring the ant(4\')-Ia gene.
CONCLUSIONS: The LC-MS/MS method presented herein demonstrates its ability to provide a reliable determination of S. aureus resistance mechanisms, directly from positive blood cultures and in a short turnaround time, as required in clinical laboratories.
方法:开发了一种快速蛋白质组学方法来检测和定量脓毒症中金黄色葡萄球菌中最临床相关的抗微生物耐药性效应物:PBP2a,PBP2c,APH(3')-III,ANT(4\')-I,和AAC(6\')-APH(2\'\'),直接从阳性血液培养物中提取,并在不到70分钟的时间内进行,包括30分钟的头孢西丁诱导步骤。该方法在接种124例金黄色葡萄球菌的加标血培养瓶上进行了测试,考虑SCCmec类型的已知基因组多样性和菌株的遗传背景。
结果:该方法为PBP2a(n=98/99菌株)检测提供了99%的一致性。PBP2c的协议为100%(n=5/5),APH(3')-III(n=16/16),和ANT(4')-I(n=20/20),AAC(6\')-APH(2\'\')(n=16/17)为94%。在整个菌株收集中,对于5种抗性蛋白中的每一种都报告了100%的负一致性。此外,ANT(4')-I表达的相对定量允许区分卡那霉素敏感和耐药菌株,在所有具有蚂蚁(4')-Ia基因的菌株中。
结论:本文提供的LC-MS/MS方法证明了其提供可靠的金黄色葡萄球菌耐药机制测定的能力,直接来自阳性血液培养,在很短的周转时间内,根据临床实验室的要求。